...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis
【24h】

Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis

机译:无症状患者和HTLV-I相关性脊髓病/热带痉挛性轻瘫的患者中的人I型T细胞淋巴病毒I型(HTLV-I)前病毒DNA病毒载量

获取原文

摘要

To evaluate the human T-cell lymphotropic virus type I (HTLV-I) proviral DNA load among asymptomatic HTLV-I-infected carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), real time PCR using TaqMan probes for the pol gene was performed in two million peripheral blood mononuclear cells (PBMC). The albumin gene was the internal genomic control and MT2 cells were used as positive control. The results are reported as copies/10,000 PBMC, and the detection limit was 10 copies. A total of 89 subjects (44 HAM/TSP and 45 healthy HTLV-I-infected carriers) followed up at the Institute of Infectious Diseases "Emilio Ribas" and in the Neurology Division of Hospital of Clínicas were studied. The asymptomatic HTLV-I-infected carriers had a median number of 271 copies (ranging from 5 to 4756 copies), whereas the HAM/TSP cases presented a median of 679 copies (5-5360 copies) in 10,000 PBMC. Thus, HAM/TSP patients presented a significantly higher HTLV-I proviral DNA load than healthy HTLV-I carriers (P = 0.005, one-way Mann-Whitney test). As observed in other persistent infections, proviral DNA load quantification may be an important tool for monotoring HTLV-I-infected subjects. However, long-term follow-up is necessary to validate this assay in the clinical setting.
机译:为了评估无症状HTLV-I感染的携带者和HTLV-I相关性脊髓病/热带痉挛性轻瘫(HAM / TSP)患者中人T细胞I型(HTLV-I)前病毒DNA负荷,使用实时PCR TaqMan探针的pol基因在200万个外周血单核细胞(PBMC)中进行。白蛋白基因是内部基因组对照,MT2细胞用作阳性对照。结果报告为每10,000 PBMC副本,检测极限为10副本。在传染病研究所“ Emilio Ribas”和克利尼卡斯医院神经病学部门对总共89位受试者(44位HAM / TSP和45位健康的HTLV-I感染的携带者)进行了随访。无症状的HTLV-I感染携带者的中位数为271份(5到4756份),而HAM / TSP病例的10,000 PBMC中位数为679份(5-5360份)。因此,HAM / TSP患者比健康的HTLV-1携带者表现出更高的HTLV-1病毒原DNA负荷(P = 0.005,单向Mann-Whitney测试)。正如在其他持续性感染中观察到的那样,前病毒DNA负载量化可能是用于控制HTLV-1感染受试者的重要工具。但是,需要长期随访以在临床环境中验证该测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号